Non-cancer-related deaths in patients with resectable locally advanced esophageal squamous cell carcinoma: A supplementary analysis of JCOG1109. Transarterial infusion chemotherapy and embolization ...

Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions.

Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.

Immune checkpoint inhibitors (ICIs) have revolutionized the field of cancer immuno-oncology. ICIs act on cancer cells by blocking the interaction between immune checkpoint proteins on immune cells and ...

Eligible patients had operable T3N0-1M0 thoracic esophageal cancer. Patients received two cycles of fluorouracil (FU) and cisplatin (days 1 to 5 and 22 to 26) and either conventional (46 Gy in 4.5 ...

Chemotherapy significantly improves overall and cancer-specific survival in cervical cancer patients undergoing radiotherapy, especially in those aged 65 to 80 years. The benefits of chemotherapy ...

A daily pill called osimertinib (Tagrisso) is delivering far longer cancer control for adults with unresectable stage 3 EGFR-mutated non-small cell lung cancer after chemoradiation and is now ...

Please provide your email address to receive an email when new articles are posted on . “Interest in organ preservation strategies for patients with rectal cancer persists,” Paul B. Romesser, MD, ...

SAN FRANCISCO -- Neoadjuvant chemoradiotherapy with or without the investigational PD-1 inhibitor sintilimab significantly increased pathological complete response (pCR) rates compared with ...

The findings on tumor mutational burden (TMB) may fill a gap in biomarkers for patients who have non–small cell lung cancer (NSCLC). The findings could make it easier for clinicians to personalize ...

Please provide your email address to receive an email when new articles are posted on . “In patients with [isocitrate dehydrogenase (IDH)] wild-type glioblastoma, epileptic seizures are common during ...

WASHINGTON — Reduced doses of radiation therapy and immunotherapy did not work as well as the standard chemoradiation for early-stage HPV-associated oropharyngeal cancer, in a new study. These ...